The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its fifth and biggest fund to date.

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...

But deciding if it's a good buy takes a little more looking.

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 by 9 percentage ...

Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full ...

We all know someone waiting on a medical breakthrough. It could be a parent battling a chronic illness, a colleague pushing ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...

Choose Pittsburgh Business Times as a preferred news source to see more of our reporting on Google. Del Brady co-founded ...